# Takeda Pharmaceutical Co Ltd: Form 4, filed May 7, 2021

- Company: [Takeda Pharmaceutical Co Ltd](/companies/tak.md) (CIK 1395064)
- Form: 4
- Filed: 2021-05-07
- Accepted by EDGAR: May 7, 2021, 07:22 ET
- Period: 2021-05-05
- Accession: 0001395064-21-000060
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1395064/000139506421000060/xslF345X03/wf-form4_162038652477240.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1395064/000139506421000060/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1395064/000139506421000060/xslF345X03/wf-form4_162038652477240.xml

Filed May 7, 2021.
Source: SEC EDGAR, the filing index for accession 0001395064-21-000060. Last ingested by Listed: Nov 5, 2026, 16:17 ET. No prices; not investment advice.
